PharmEasy

PharmEasy's Valuation Slashed By Almost 50% to $2.8 Bn By Investor

Online drug marketplace PharmEasy has seen a 50% drop in its valuation. It's investor Janus Henderson has slashed its valuation to $2.8 bn. This marks the second valuation reduction for the company, as Neuberger Berman lowered its valuation to $4.4 bn.